Literature DB >> 24723663

High risk for seizures following subarachnoid hemorrhage regardless of referral bias.

Kathryn L O'Connor1, M Brandon Westover, Michael T Phillips, Nicolae A Iftimia, Deidre A Buckley, Christopher S Ogilvy, Mouhsin M Shafi, Eric S Rosenthal.   

Abstract

BACKGROUND: To investigate the frequency, predictors, and clinical impact of electrographic seizures in patients with high clinical or radiologic grade non-traumatic subarachnoid hemorrhage (SAH), independent of referral bias.
METHODS: We compared rates of electrographic seizures and associated clinical variables and outcomes in patients with high clinical or radiologic grade non-traumatic SAH. Rates of electrographic seizure detection before and after institution of a guideline which made continuous EEG monitoring routine in this population were compared.
RESULTS: Electrographic seizures occurred in 17.6 % of patients monitored expressly because of clinically suspected subclinical seizures. In unselected patients, seizures still occurred in 9.6 % of all cases, and in 8.6 % of cases in which there was no a priori suspicion of seizures. The first seizure detected occurred 5.4 (IQR 2.9-7.3) days after onset of subarachnoid hemorrhage with three of eight patients (37.5 %) having the first recorded seizure more than 48 h following EEG initiation, and 2/8 (25 %) at more than 72 h following EEG initiation. High clinical grade was associated with poor outcome at time of hospital discharge; electrographic seizures were not associated with poor outcome.
CONCLUSIONS: Electrographic seizures occur at a relatively high rate in patients with non-traumatic SAH even after accounting for referral bias. The prolonged time to the first detected seizure in this cohort may reflect dynamic clinical features unique to the SAH population.

Entities:  

Mesh:

Year:  2014        PMID: 24723663      PMCID: PMC4878846          DOI: 10.1007/s12028-014-9974-y

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  23 in total

Review 1.  Which EEG patterns warrant treatment in the critically ill? Reviewing the evidence for treatment of periodic epileptiform discharges and related patterns.

Authors:  Derek J Chong; Lawrence J Hirsch
Journal:  J Clin Neurophysiol       Date:  2005-04       Impact factor: 2.177

Review 2.  Seizures after aneurysmal subarachnoid hemorrhage: a systematic review of outcomes.

Authors:  Daniel M S Raper; Robert M Starke; Ricardo J Komotar; Rodney Allan; E Sander Connolly
Journal:  World Neurosurg       Date:  2012-09-25       Impact factor: 2.104

3.  Early rebleeding after coiling of ruptured cerebral aneurysms: incidence, morbidity, and risk factors.

Authors:  Menno Sluzewski; Willem Jan van Rooij
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

4.  Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects.

Authors:  Mervyn D I Vergouwen; Don Ilodigwe; R Loch Macdonald
Journal:  Stroke       Date:  2011-02-10       Impact factor: 7.914

5.  Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association.

Authors:  E Sander Connolly; Alejandro A Rabinstein; J Ricardo Carhuapoma; Colin P Derdeyn; Jacques Dion; Randall T Higashida; Brian L Hoh; Catherine J Kirkness; Andrew M Naidech; Christopher S Ogilvy; Aman B Patel; B Gregory Thompson; Paul Vespa
Journal:  Stroke       Date:  2012-05-03       Impact factor: 7.914

6.  Epilepsy after operative treatment of ruptured cerebral aneurysms.

Authors:  V Ukkola; E R Heikkinen
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

7.  Late epilepsy after aneurysm operations.

Authors:  T Keränen; A Tapaninaho; J Hernesniemi; M Vapalahti
Journal:  Neurosurgery       Date:  1985-12       Impact factor: 4.654

8.  Effect of clipping, craniotomy, or intravascular coiling on cerebral vasospasm and patient outcome after aneurysmal subarachnoid hemorrhage.

Authors:  Brian L Hoh; Mehmet A Topcuoglu; Aneesh B Singhal; Johnny C Pryor; James D Rabinov; Guy A Rordorf; Bob S Carter; Christopher S Ogilvy
Journal:  Neurosurgery       Date:  2004-10       Impact factor: 4.654

9.  Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis.

Authors:  Dennis J Nieuwkamp; Larissa E Setz; Ale Algra; Francisca H H Linn; Nicolien K de Rooij; Gabriël J E Rinkel
Journal:  Lancet Neurol       Date:  2009-06-06       Impact factor: 44.182

10.  Quantitative continuous EEG for detecting delayed cerebral ischemia in patients with poor-grade subarachnoid hemorrhage.

Authors:  Jan Claassen; Lawrence J Hirsch; Kurt T Kreiter; Evelyn Y Du; E Sander Connolly; Ronald G Emerson; Stephan A Mayer
Journal:  Clin Neurophysiol       Date:  2004-12       Impact factor: 3.708

View more
  9 in total

1.  Continuous electroencephalography predicts delayed cerebral ischemia after subarachnoid hemorrhage: A prospective study of diagnostic accuracy.

Authors:  Eric S Rosenthal; Siddharth Biswal; Sahar F Zafar; Kathryn L O'Connor; Sophia Bechek; Apeksha V Shenoy; Emily J Boyle; Mouhsin M Shafi; Emily J Gilmore; Brandon P Foreman; Nicolas Gaspard; Thabele M Leslie-Mazwi; Jonathan Rosand; Daniel B Hoch; Cenk Ayata; Sydney S Cash; Andrew J Cole; Aman B Patel; M Brandon Westover
Journal:  Ann Neurol       Date:  2018-05-16       Impact factor: 10.422

2.  Consensus statement on continuous EEG in critically ill adults and children, part I: indications.

Authors:  Susan T Herman; Nicholas S Abend; Thomas P Bleck; Kevin E Chapman; Frank W Drislane; Ronald G Emerson; Elizabeth E Gerard; Cecil D Hahn; Aatif M Husain; Peter W Kaplan; Suzette M LaRoche; Marc R Nuwer; Mark Quigg; James J Riviello; Sarah E Schmitt; Liberty A Simmons; Tammy N Tsuchida; Lawrence J Hirsch
Journal:  J Clin Neurophysiol       Date:  2015-04       Impact factor: 2.177

Review 3.  Noninvasive Neuromonitoring: Current Utility in Subarachnoid Hemorrhage, Traumatic Brain Injury, and Stroke.

Authors:  Luisa Vinciguerra; Julian Bösel
Journal:  Neurocrit Care       Date:  2017-08       Impact factor: 3.210

4.  Time to electroencephalography is independently associated with outcome in critically ill neonates and children.

Authors:  Iván Sánchez Fernández; Arnold J Sansevere; Rejean M Guerriero; Ersida Buraniqi; Phillip L Pearl; Robert C Tasker; Tobias Loddenkemper
Journal:  Epilepsia       Date:  2017-01-28       Impact factor: 5.864

Review 5.  Continuous EEG monitoring in aneurysmal subarachnoid hemorrhage: a systematic review.

Authors:  Daniel Kondziella; Christian K Friberg; Ian Wellwood; Clemens Reiffurth; Martin Fabricius; Jens P Dreier
Journal:  Neurocrit Care       Date:  2015-06       Impact factor: 3.210

6.  Prophylactic Antiepileptics and Seizure Incidence Following Subarachnoid Hemorrhage: A Propensity Score-Matched Analysis.

Authors:  David Panczykowski; Matthew Pease; Yin Zhao; Gregory Weiner; William Ares; Elizabeth Crago; Brian Jankowitz; Andrew F Ducruet
Journal:  Stroke       Date:  2016-06-14       Impact factor: 7.914

7.  Epileptiform abnormalities predict delayed cerebral ischemia in subarachnoid hemorrhage.

Authors:  J A Kim; E S Rosenthal; S Biswal; S Zafar; A V Shenoy; K L O'Connor; S C Bechek; J Valdery Moura; M M Shafi; A B Patel; S S Cash; M B Westover
Journal:  Clin Neurophysiol       Date:  2017-01-29       Impact factor: 3.708

8.  Soluble ST2 Is Associated With New Epileptiform Abnormalities Following Nontraumatic Subarachnoid Hemorrhage.

Authors:  W Taylor Kimberly; Eric S Rosenthal; India A Lissak; Sahar F Zafar; M Brandon Westover; Riana L Schleicher; Jennifer A Kim; Thabele Leslie-Mazwi; Christopher J Stapleton; Aman B Patel
Journal:  Stroke       Date:  2020-03-11       Impact factor: 7.914

9.  Prediction and Risk Assessment Models for Subarachnoid Hemorrhage: A Systematic Review on Case Studies.

Authors:  Jewel Sengupta; Robertas Alzbutas
Journal:  Biomed Res Int       Date:  2022-01-27       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.